Computational and Structural Biotechnology Journal (Jan 2021)

The paradoxical problem with COVID-19 ocular infection: Moderate clinical manifestation and potential infection risk

  • Jiawei Shen,
  • Jian Wu,
  • Yang Yang,
  • Pengcheng Wang,
  • Tao Luo,
  • Yanju Guo,
  • Jun Zhao,
  • Wei Dai,
  • Ying Han,
  • Peiran Zhu,
  • Qiuyue Wu,
  • Weiwei Li,
  • Andrew Chen,
  • Chunyan Xue,
  • Xinyi Xia

Journal volume & issue
Vol. 19
pp. 1063 – 1071

Abstract

Read online

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which induced mainly the respiratory damage also caused ocular surface symptoms. However, the detailed description of ocular manifestations, severity fluctuations in confirmed COVID-19 adult patients still lacked. We analyzed onset clinical symptoms and duration, ocular symptoms, needs for medication, outcomes in 28 conjunctivitis patients who were extracted from 3198 COVID-19 patients hospitalized in Huoshenshan Hospital and Taikangtongji Hospital, Wuhan, China. The expression levels of ACE2, TMPRSS2, ANPEP, DPP4, NRP1 on fetal and adult ocular surface and mouse lacrimal glands were assessed by single cell seq analysis. Our results indicated that conjunctivitis was a rare and self-limited complication in adults with COVID-19 while the existence of coronavirus receptors on human ocular surface and mouse lacrimal glands indicated the risk of SARS-CoV-2 infection. Our research firstly examined SARS-CoV-2 receptors, including the new discovered one, NRP1, on the fetal ocular surface and in the mouse lacrimal glands.

Keywords